Key Points
- CorVel director R. Judd Jessup sold 4,023 shares at an average price of $70.07, generating approximately $281,892 and reducing his ownership by 3.47% to 111,798 shares. He also sold additional shares in late August.
- CorVel shares opened at $68.68, with the stock down 2.4%; the company has a $3.50 billion market capitalization, a P/E ratio of 30.52, and a 52-week range of $44.83 to $93.45.
- The company reported quarterly EPS of $0.63 on revenue of $259.93 million, while analyst sentiment remains at an average “Hold” rating. Institutional ownership stands at 51.36%, with several major investors recently increasing or initiating positions.
CorVel Corp. (NASDAQ:CRVL - Get Free Report) Director R. Jessup sold 4,023 shares of the business's stock in a transaction dated Tuesday, September 1st. The stock was sold at an average price of $70.07, for a total transaction of $281,891.61. Following the completion of the transaction, the director owned 111,798 shares of the company's stock, valued at $7,833,685.86. This represents a 3.47% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
R Judd Jessup also recently made the following trade(s):
- On Thursday, August 27th, R. Jessup sold 1,262 shares of CorVel stock. The shares were sold at an average price of $70.64, for a total transaction of $89,147.68.
- On Wednesday, August 26th, R. Jessup sold 1,562 shares of CorVel stock. The shares were sold at an average price of $70.71, for a total transaction of $110,449.02.
CorVel Stock Down 2.4%
Shares of CorVel stock opened at $68.68 on Friday. The firm's 50 day moving average price is $64.14 and its 200-day moving average price is $58.93. CorVel Corp. has a 52-week low of $44.83 and a 52-week high of $93.45. The company has a market cap of $3.50 billion, a P/E ratio of 30.52 and a beta of 0.97.
CorVel (NASDAQ:CRVL - Get Free Report) last posted its earnings results on Tuesday, August 4th. The business services provider reported $0.63 EPS for the quarter. The company had revenue of $259.93 million during the quarter. CorVel had a net margin of 11.72% and a return on equity of 29.92%.
Analyst Ratings Changes
CRVL has been the subject of several analyst reports. Wall Street Zen upgraded CorVel from a "hold" rating to a "buy" rating in a report on Saturday, May 30th. Weiss Ratings raised CorVel from a "hold (c-)" rating to a "hold (c)" rating in a research report on Tuesday. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the stock currently has an average rating of "Hold".
Get Our Latest Stock Analysis on CRVL
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of CRVL. BlackRock Inc. acquired a new stake in shares of CorVel during the second quarter worth about $321,316,000. California State Teachers Retirement System raised its position in CorVel by 7,962.8% during the 2nd quarter. California State Teachers Retirement System now owns 2,350,314 shares of the business services provider's stock worth $146,942,000 after buying an additional 2,321,164 shares during the last quarter. State Street Corp raised its position in CorVel by 2.7% during the 4th quarter. State Street Corp now owns 1,179,572 shares of the business services provider's stock worth $79,822,000 after buying an additional 30,987 shares during the last quarter. Geode Capital Management LLC lifted its stake in CorVel by 3.2% during the 4th quarter. Geode Capital Management LLC now owns 927,845 shares of the business services provider's stock valued at $62,796,000 after acquiring an additional 28,666 shares during the period. Finally, Norges Bank acquired a new stake in CorVel during the 4th quarter valued at approximately $29,250,000. 51.36% of the stock is currently owned by hedge funds and other institutional investors.
About CorVel
(
Get Free Report)
CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers' compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel's integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.
The company's product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
